000756 新华制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资59,9072.28%58,57257,15456,70757,796
投资性房地产33,412-1.47%33,90948,35445,76650,017
固定资产3,476,8474.54%3,325,9453,447,8893,195,1123,117,313
在建工程671,137-8.13%730,545545,895562,959416,990
无形资产476,519-3.72%494,937474,107466,451449,247
商誉0--0000
其他非流动资产377,37215.08%327,925234,432251,080314,718
5,095,1942.48%4,971,8334,807,8314,578,0754,406,081

流动资产
货币资金996,3328.49%918,3341,158,742744,662855,771
应收账款1,022,66246.12%699,878761,259658,568379,909
存货1,191,617-9.24%1,312,9841,211,9871,027,5401,124,364
其他流动资产428,05411.72%383,138324,971323,188326,827
3,638,6659.79%3,314,3343,456,9592,753,9582,686,871

流动负债
短期借款378,39933.26%283,959118,023269,455200,420
应付票据549,5357.45%511,431491,025405,072289,973
应付帐款670,4090.60%666,413599,056661,320452,930
其他流动负债1,015,375-0.86%1,024,1981,950,3821,166,0341,437,716
2,613,7185.14%2,486,0003,158,4862,501,8802,381,039
流动资产净值1,024,94723.74%828,333298,474252,078305,832
资产总额减流动负债6,120,1415.52%5,800,1665,106,3054,830,1534,711,913

非流动负债
长期借款912,19114.11%799,400545,656346,197462,738
应付债券0--0000
其他非流动负债233,3023.68%225,013211,085832,812857,885
1,145,49311.82%1,024,413756,7411,179,0081,320,623

总权益
    实收股本682,4081.14%674,683669,627627,367621,859
    储备项目4,071,6584.98%3,878,4213,456,6472,840,5742,601,934
股东权益4,754,0664.41%4,553,1044,126,2743,467,9423,223,794
非控股权益220,582-0.93%222,649223,290183,203167,496